Research

A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.

Study finds that reducing intake of simple sugars improves GERD

Oct. 6, 2022—A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Oct. 4, 2022—Andrew Terker, MD, PhD, a physician scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

VUMC lands grant to build top-line biosafety facility

Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.

Policy, resources crucial for lung cancer screening: study

Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Vanderbilt Translational Research Forum set for Oct. 21

Sep. 29, 2022—Vanderbilt Translational Research Forum, an annual celebration of the “translation” of scientific discovery into clinical practice, will be held Oct. 21 at the Vanderbilt University Student Life Center.

Diagnostic biomarker for bone disorder

Sep. 27, 2022—A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.

Gender differences with bladder pain

Sep. 26, 2022—Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

Colon cancer researchers awarded NCI grant for study of early lesions

Sep. 22, 2022—Vanderbilt researchers are studying precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation’s second leading cancer killer.

Medical laboratory scientist Gladys Garrison, MT, MS, loads reagents to prepare DNA samples for analysis in the VUMC Molecular Diagnostics Lab.

Nominations sought for Research Staff Awards

Sep. 22, 2022—Nominations for the 2022 Vanderbilt University School of Medicine Research Staff Awards are now being accepted.

Reduced exercise capacity in ICU survivors

Sep. 22, 2022—ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.

Nerve cells and cancer progression

Sep. 22, 2022—Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.

Study suggests new mechanism for lipid transporter

Sep. 15, 2022—A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.